Literature DB >> 24912910

The ocular surface: from physiology to the ocular allergic diseases.

Jorge Galicia-Carreón1, Concepción Santacruz, Enrique Hong, María C Jiménez-Martínez.   

Abstract

Allergic conjunctivitis (AC) is an inflammation of the conjunctiva secondary to an immune response to exogenous antigens, usually called allergens. In fact, AC is a syndrome that involves the entire ocular surface, including conjunctiva, lids, cornea, and tear film. The signs and symptoms of AC have a meaningful effect on comfort and patient health, and could be influenced by environment, genetics and immune regulation mechanisms, all of which work together in a complex immunological homeostasis. Dysregulation in such immune responses could turn into a variety of ocular allergic diseases (OAD). This review describes some of the current understanding of cellular and molecular pathways involved in different OAD.

Entities:  

Keywords:  Allergic conjunctivitis; CD4+ T cells; Ocular allergic diseases; Tregs

Mesh:

Substances:

Year:  2013        PMID: 24912910

Source DB:  PubMed          Journal:  Rev Alerg Mex        ISSN: 0002-5151


  4 in total

Review 1.  Therapeutic Targets in Allergic Conjunctivitis.

Authors:  Bisant A Labib; DeGaulle I Chigbu
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-28

Review 2.  Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis.

Authors:  DeGaulle I Chigbu; Alissa M Coyne
Journal:  Clin Ophthalmol       Date:  2015-07-08

Review 3.  Potential Biomarkers for Allergic Conjunctival Diseases.

Authors:  Neeta Roy; Shir Levanon; Penny A Asbell
Journal:  Eye Contact Lens       Date:  2020-03       Impact factor: 3.152

4.  Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy.

Authors:  Veronica Tisato; Paolo Perri; Erika Rimondi; Elisabetta Melloni; Giuseppe Lamberti; Daniela Milani; Paola Secchiero; Giorgio Zauli
Journal:  Mediators Inflamm       Date:  2015-10-07       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.